PHARMACY

Mylan gets FDA nod for generic Adalat CC

BY Alaric DeArment

PITTSBURGH — The Food and Drug Administration has approved a generic drug for hypertension made by Mylan.

Mylan announced Friday the approval of nifedipine extended-release tablets in the 30-mg, 60-mg and 90-mg strengths. The drug is a generic version of Bayer’s Adalat CC.

Nifedipine tablets had sales of around $82 million during the 12-month period ended in June, according to IMS Health.

keyboard_arrow_downCOMMENTS

Leave a Reply

No comments found

TRENDING STORIES

Polls

Which area of the industry do you think Amazon's entry would shake up the most?
PHARMACY

Universal American announces 2010 Community CCRx Pharmacy of the Year

BY Alaric DeArment

RYE BROOK, N.Y. — The second-largest Medicare Part D plan sponsor in the country has named an independent pharmacy as its pharmacy of the year.

Universal American announced Thursday that it gave the 2010 Community CCRx Pharmacy of the Year recognition to Peterson Drug and Gifts in Mountain Lake, Minn. The award takes its name from Universal American’s Community CCRx Prescription Drug plans, in which Peterson Drug and Gifts participates.

“The foundation of the Community CCRx is to provide members with a supportive relationship we call ‘A Healthy Collaboration,’” Universal American Medicare prescription drug plan business president John Wardle stated. “Pharmacists help our members understand their drug regimens, counsel patients to prevent dangerous drug interactions and work to save members money by helping them switch to lower-cost, equally effective medications when appropriate.”

Universal American said Peterson Drug and Gifts received the award in recognition of its work inside and outside the pharmacy, having reached the highest possible tiers for generic dispensing and maintenance supply rates, and having completed 90% of its available medication therapy management cases.

keyboard_arrow_downCOMMENTS

Leave a Reply

No comments found

TRENDING STORIES

Polls

Which area of the industry do you think Amazon's entry would shake up the most?
PHARMACY

Medco study: Half of women 40 years and older don’t get annual mammograms

BY Alaric DeArment

SAN ANTONIO — Despite recommendations, half of women ages 40 years and older do not get annual mammograms, according to a new study by pharmacy benefit manager Medco.

The analysis, from the Medco Research Institute, also found that nearly 40% of women ages 50 years and older don’t get biennial screenings. Data from the study will be presented at the 33rd annual CTRC-AACR San Antonio Breast Cancer Symposium.

The study was based on anonymous medical claims data collected between 2006 and 2009 from more than 1.5 million women. Mammograms are considered an important means of detecting breast cancer and can detect most cases of the disease in women who aren’t showing symptoms.

“These findings provide stark evidence that we need to do a much better job at encouraging women to have regular mammograms,” breast cancer specialist and BreastCancer.org founder Marisa Weiss stated. Weiss recently was diagnosed with breast cancer through a routine mammogram.

The National Cancer Institute estimated that 1-in-8 women will develop cancer during their lifetimes, and the American Cancer Society estimated that 207,000 new cases of the disease will be diagnosed this year.

keyboard_arrow_downCOMMENTS

Leave a Reply

No comments found

TRENDING STORIES

Polls

Which area of the industry do you think Amazon's entry would shake up the most?